Midbrain muscarinic receptor mechanisms underlying regulation of mesoaccumbens and nigrostriatal dopaminergic transmission in the rat

European Journal of Neuroscience

Volumn 21, Issue 7, 2005, Pages 1837-1846

  Miller, Anthony D ^a   Blaha, Charles D ^b  

^a MACQUARIE UNIVERSITY   (Australia)

^b University of Memphis   (United States)

Author keywords

Acetylcholine; Chronoamperometry; Mesopontine; Substantia nigra; Ventral tegmental area

Indexed keywords

ACETYLCHOLINE; CARBACHOL; DOPAMINE; GLUTAMINE; MUSCARINE; MUSCARINIC M3 RECEPTOR; MUSCARINIC M5 RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NICOTINIC AGENT; SCOPOLAMINE;

AMPEROMETRY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; INTERNEURON; MALE; MESENCEPHALON; NERVE EXCITABILITY; NONHUMAN; NUCLEUS ACCUMBENS; PONS; PRIORITY JOURNAL; SUBSTANTIA NIGRA; TEGMENTUM; VENTRAL TEGMENTUM; ZONA COMPACTA;

ANIMALS; CARBACHOL; CHOLINERGIC AGONISTS; DOPAMINE; DRUG INTERACTIONS; ELECTROCHEMISTRY; ELECTRODES; MALE; MUSCARINIC ANTAGONISTS; NUCLEUS ACCUMBENS; PIPERIDINES; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC; SCOPOLAMINE; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION; VENTRAL TEGMENTAL AREA;

EID: 18844375373     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2005.04017.x     Document Type: Article

References (93)

1. Alderson, H.L., Latimer, M.P., Blalia, C.D., Phillips, A.C. & Winn, P. (2004) An examination of d-amphetamine self-administration in pedunculopontine tegmental nucleus-lesioned rats. Neuroscience, 125, 349-358.
2. Basile, A.S., Fedorova, I., Zapata, A., Liu, X., Shippenberg, T., Duttaroy, A., Yamada, M. & Wess, J. (2002) Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia. Proc. Natl. Acad. Sci. USA, 99, 11452-11457.
3. Bauco, P. & Wise, R.A. (1994) Potentiation of lateral hypothalamic and midline mesencephalic brain stimulation reinforcement by nicotine: examination of repeated treatment. J. Pharmacol. Exp. Ther., 271, 294-301.
4. Blaha, C.D. (1996) Evaluation of stearate-graphite paste electrodes for chronic measurement of extracellular dopamine concentrations in the mammalian brain. Pharmacol. Biochem. Behav., 55, 351-364.
5. Blaha, C.D., Allen, L.F., Das, S., Inglis, W.L., Latimer, M.P., Vincent, S.R. & Winn, P. (1996a) Modulation of dopamine efflux in the nucleus accumbens after cholinergic stimulation of the ventral tegmental area in intact, pedunculopontine tegmental nucleus-lesioned, and laterodorsal tegmental nucleus-lesioned rats. J. Neurosci., 16, 714-722.
6. Blaha, C.D. & Jung, M.E. (1991) Electrochemical evaluation of stearate modified graphite paste electrodes: selective detection of dopamine is maintained after exposure to brain tissue. J. Electroanal. Chem., 310, 317-334.
7. Blaha, C.D., Lui, D. & Phillips, A.G. (1996b) Improved electrochemical properties of stearate-graphite paste electrodes after albumin and phospholipid treatments. Biosens. Bioelectron., 11, 63-79.
8. Blaha, C.D. & Phillips, A.G. (1996) A critical assessment of electrochemical procedures applied to the measurement of dopamine and its metabolites during drug-induced and species-typical behaviours. Behav. Pharmacol., 7, 675-708.
9. Blaha, C.D. & Winn, P. (1993) Modulation of dopamine efflux in the striatum following cholinergic stimulation of the substantia nigra in intact and pedunculopontine tegmental nucleus-lesioned rats. J. Neurosci., 13, 1035-1044.
10. Bolden, C., Cusack, B. & Richelson, E. (1992) Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells. J. Pharmacol. Exp. Ther., 260, 576-580.
11. Bymaster, P.P., Shannon, H.E., Rasmussen, K., DeLapp, N.W., Ward, J.S., Calligaro, D.O., Mitch, C.H., Whitesitt, C., Ludvigsen, T.S., Sheardown, M., Swedberg, M., Rasmussen, T., Olesen, P.H., Jeppesen, L., Sauerberg, P. & Fink-Jensen, A. (1999) Potential role of muscarinic receptors in schizophrenia. Life Sci., 64, 527-534.
12. Calabresi, P., Lacey, M.G. & North, R.A. (1989) Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording. Br. J. Pharmacol., 98, 135-140.
13. Celada, P., Paladini, C.A. & Tepper, J.M. (1999) GABAergic control of rat substantia nigra dopaminergic neurons: role of globus pallidus and substantia nigra pars reticulata. Neuroscience, 89, 813-825.
14. Champtiaux, N., Gotti, C. Cordero-Erausquin, M., David, D.J., Przybylski, C., Lena, C., Clementi, F., Moretti, M., Rossi, P.M., Le Novere, N., McIntosh, J.M., Gardier, A.M. & Changeux, J.P. (2003) Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. J. Neurosci., 23, 7820-7829.
15. Chapman, C.A., Yeomans, J.S., Blaha, C.D. & Blackburn, J.R. (1997) Increased striatal dopamine efflux follows scopolamine administered systemically or to the tegmental pedunculopontine nucleus. Neuroscience, 76, 177-186.
16. Charpantier, E., Barneoud, P., Moser, P., Besnard, F. & Sgard, F. (1998) Nicotinic acetylcholine subunit mRNA expression in dopaminergic neurons of the rat substantia nigra and ventral tegmental area. Neuroreport, 9, 3097-3101.
17. Chessell, I.P. & Humphrey, P.P. (1995) Nicotinic and muscarinic receptor-evoked depolarizations recorded from a novel cortical brain slice preparation. Neuropharmacology, 34, 1289-1296.
18. Corrigall, W.A., Coen, K.M. & Adamson, K.L. (1994) Self-administered nicotine activates the mesolimbic dopamine system via the ventral tegmental area. Brain Res., 653, 278-284.
19. Corrigall, W.A., Coen, K.M., Zhang, J. & Adamson, K.L. (2002) Pharmacological manipulations of the pedunculopontine tegmental nucleus in the rat reduce self-administration of both nicotine and cocaine. Psychopharmacology, 160, 198-205.
20. De Luca, V., Wang, H., Squassina, A., Wong, G.W., Yeomans, J. & Kennedy, J.L. (2004) Linkage of M5 muscarinic and α7-nicotinic receptor genes on 15q13 to schizophrenia. Neuropsychobiology, 50, 124-127.
21. Dorje, F., Wess, J., Lambrecht, G., Tacke, R., Mutschler, E. & Brann, M.R. (1991) Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J. Pharmacol. Exp. Ther., 256, 727-733.
22. Eglen, R.M. & Nahorski, S.R. (2000) The muscarinic M5 receptor: a silent or emerging subtype? Br. J. Pharmacol., 130, 13-21.
23. Eglen, R.M. & Watson, N. (1996) Selective muscarinic receptor agonists and antagonists. Pharmacol. Toxicol., 78, 59-68.
24. Floresco, S.B., West, A.R., Ash, B., Moore, H. & Grace, A.A. (2003) Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat. Neurosci., 6, 968-973.
25. Forster, G.L. & Blaha, C.D. (2000) Laterodorsal tegmental stimulation elicits dopamine efflux in the rat nucleus accumbens by activation of acetylcholine and glutamate receptors in the ventral tegmental area. Eur. J. Neurosci., 12, 3596-3604.
26. Forster, G.L. & Blaha, C.D. (2003) Pedunculopontine tegmental Stimulation evokes striatal dopamine efflux by activation of acetylcholine and glutamate receptors in the midbrain and pons of the rat. Eur. J. Neurosci., 17, 751-762.
27. Forster, G.L., Yeomans, J.S., Takeuchi, J. & Blaha, C.D. (2001) M5 muscannic receptors are required for prolonged accumbal dopamine release following, electrical stimulation of the pons in mice. J. Neurosci., 22, RC190, 1-6.
28. Frey, K.A. & Howland, M.M. (1992) Quantitative autoradiography of muscannic cholinergic receptor binding in the rat brain: distinction of receptor subtypes in antagonist competition assays. J. Pharmacol. Exp. Ther., 263, 1391-1400.
29. Garzon, M., Vaughan, R.A., Uhl, G.R., Kuhar, M.J. & Pickel, V.M. (1999) Cholinergic axon terminals in the ventral tegmental area target a subpopulation of neurons expressing low levels of the dopamine transporter. J. Comp. Neurol., 410, 197-210.
30. Gejman, P. V., Sanders, A.R., Badner, J.A., Cao, Q. & Zhang, J. (2001) Linkage analysis of schizophrenia to chromosome 15. Am. J. Med. Genet., 105, 789-793.
31. Giorgetti, M., Hotsenpiller, G., Froestl, W. & Wolf, M.E. (2002) In vivo modulation of ventral tegmental area dopamine and glutamate efflux by local GABA (B) receptors is altered after repeated amphetamine treatment. Neuroscience, 109, 585-595.
32. Gongora-Alfaro, J.L., Hernandez-Lopez, S., Martinez-Fong, D., Flores, G. & Aceves, J. (1996) Circling behavior elicited by cholinergic transmission in the substantia nigra pars compacta: involvement of nicotinic and muscannic receptors. Neuroscience, 71, 729-734.
33. Grace, A.A. (1991) Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience, 41, 1-24.
34. Grace, A.A. & Bunney, B.S. (1979) Paradoxical GABA excitation of nigral dopaminergic cells: indirect mediation through reticulata inhibitory neurons. Eur. J. Pharmacol., 59, 211-218.
35. Grace, A.A. & Bunney, B.S. (1985) Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity. Brain Res., 333, 271-284.
36. Gray, J.A. (1998) Integrating schizophrenia. Schizophr. Bull., 24, 249-266.
37. Gray, J.A., Moran, P.M., Grigoryan, G., Peters, S.L., Young, A.M. & Joseph, M.H. (1997) Latent inhibition: the nucleus accumbens connection revisited. Behav. Brain Res., 88, 27-34.
38. Gray, N.S., Pilowsky, L.S., Gray, J.A. & Krwin, R.W. (1995) Latent inhibition in drug naïve schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET. Schizophr. Res., 17, 95-107.
39. Grillner, P., Berretta, N., Bernardi, G., Svensson, T.H. & Mercuri, N.B. (2000) Muscarinic receptors depress GABAergic synaptic transmission in rat midbrain dopamine neurons. Neuroscience, 96, 299-307.
40. Grillner, P., Bonci, A., Svensson, T.H., Bernardi, G. & Mercuri, N.B. (1999) Presynaptic muscannic (M3) receptors reduce excitatory transmission in dopamine neurons of the rat mesencephalon. Neuroscience, 91, 557-565.
41. Grillner, P. & Mercuri, N.B. (2002) Intrinsic membrane properties and synaptic inputs regulating the firing activity of the dopamine neurons. Behav. Brain Res., 130, 149-169.
42. Gronier, B., Perry, K.W. & Rasmussen, K. (2000) Activation of the mesocorticolimbic dopaminergic system by stimulation of muscannic cholinergic receptors in the ventral tegmental area. Psychopharmacology, 147, 347-355.
43. Gronier, B. & Rasmussen, K. (1998) Activation of midbrain presumed dopaminergic neurones by muscarinic cholinergic receptors: an in vivo electrophysiological study in the rat. Br. J. Pharmacol., 124, 455-464.
44. Izurieta-Sanchez, P., Sarre, S., Ebinger, G. & Michotte, Y. (2000) Muscarinic antagonists in substantia nigra influence the decarboxylation of L-dopa in striatum. Eur. J. Pharmacol., 399, 151-160.
45. Joseph, M.H., Peters, S.L., Moran, P.M., Grigoryan, G.A. & Gray, J.A. (2000) Modulation of latent inhibition in the rat by altered dopamine transmission in the nucleus accumbens at the time of conditioning. Neuroscience, 101, 921-930.
46. Joyce, E.M. & Koob, G.F. (1981) Amphetamine-, scopolamine- and caffeine-induced locomotor activity following 6-hydroxydopamine lesions of the mesolimbic dopamine system. Psychopharmacology, 73, 311-313.
47. Kitai, S.T., Shepard, P.D., Callaway, J.C. & Scroggs, R. (1999) Afferent modulation of dopamine neuron firing patterns. Cuir. Opin. Neurobiol., 9, 690-697.
48. Klink, R., de Kerchove d'Exaerde, A., Zoli, M. & Changeux, J.P. (2001) Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J. Neurosci., 21, 1452-1463.
49. Kofman, O., McGlynn, S.U., Olmstead, M.C. & Yeomans, J.S. (1990) Differential effects of atropine, procaine, and dopamine in the rat ventral tegmentum on lateral hypothalamic rewarding brain stimulation. Behav. Brain Res., 38, 55-68.
50. Kofman, O. & Yeomans, J.S. (1989) Cholinergic antagonists in ventral tegmentum elevate thresholds for lateral hypothalamic and brainstem self-stimulation. Pharmacol. Biochem. Behav., 31, 547-559.
51. Lacey, M.G. (1993) Neurotransmitter receptors and ionic conductances regulating the activity of neurones in substantia nigra pars compacta and ventral tegmental area. Prog. Brain Res., 99, 251-276.
52. Lacey, M.G., Calabresi, P. & North, R.A. (1990) Muscarine depolarizes rat substantia nigra zona compacta and ventral tegmental neurons in vitro through M1-like receptors. J. Pharmacol. Exp. Ther., 253, 395-400.
53. LaViolette, S.R., Priebe, R.P. & Yeomans, J.S. (2000) Role of the laterodorsal tegmental nucleus in scopolamine- and amphetamine-induced locomotion and stereotypy. Pharmacol. Biochem. Behav., 65, 163-174.
54. Levey, A.I. (1993) Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sci., 52, 441-448.
55. Lucchelli, A., Boselli, C. & Grana, E. (1987) Determination of dissociation constants and relative efficacies of some muscarinic agonists at nicotinic receptors. Farmaco [Sci.]., 42, 619-627.
56. Mathur, A., Shandarin, A., LaViolette, S.R., Parker, J. & Yeomans, J.S. (1997) Locomotion and stereotypy induced by scopolamine: contributions of muscarinic receptors near the pedunculopontine tegmental nucleus. Brain Res., 775, 144-155.
57. Matsubayashi, H., Amano, T., Seki, T., Sasa, M. & Sakai, N. (2003) Electrophysiological characterization of nicotine-induced excitation of dopaminergic neurons in the rat substantia nigra. J. Pharmacol. Sci., 93, 143-148.
58. Michel, F.J., Robillard, J.M. & Louis-Eric, T. (2004) Regulation of rat mesencephalic GABAergic neurones through muscarinic receptors. J. Physiol. (Lond.), 556, 429-445.
59. Miller, A.D. & Blaha, C.D. (2004) Regulation of nigrostriatal dopamine transmission by hindbrain muscarinic receptors. Neuroreport, 15, 1805-1808.
60. Miller, A.D., Forster, G.L., Metcalf, K. & Blaha, C.D. (2002) Excitotoxic lesions of the pedunculopontine differentially mediate morphine and d-amphetamine evoked striatal dopamine efflux and behaviors. Neuroscience, 111, 351-362.
61. Miller, A.D., Stockton, J.M. & Blaha, C.D. (2003) Comparison of cholinergic receptor mechanisms underlying tonic regulation and phasic modulation of nigrostriatal and mesoaccumbens dopamine transmission. Soc. Neurosci. Abstr., 29, 246.1.
62. Moser, P.C., Hitchcock, J.M., Lister, S. & Moran, P.M. (2000) The pharmacology of latent inhibition as an animal model of schizophrenia. Brain Res. Rev., 33, 275-307.
63. Nisell, M., Nomikos, G.G. & Svensson, T.H. (1994a) Systemic nicotine induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse, 16, 36-44.
64. Nisell, M., Nomikos, G.G. & Svensson, T.H. (1994b) Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release. Pharmacol. Toxicol., 75, 348-352.
65. Oakman, S.A., Paris, P.L., Kerr, P.E., Cozzari, C. & Hartman, B.K. (1995) Distribution of pontomesencephalic cholinergic neurons projecting to the substantia nigra differs significantly from those projecting to the ventral tegmental area. J. Neurosci., 15, 5859-5869.
66. Paladini, C.A., Celada, P. & Tepper, J.M. (1999) Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA (A) receptors in vivo. Neuroscience, 89, 799-812.
67. Paxinos, G. & Watson, C. (1997) The Rat Brain in Stereotaxic Coordinates, 3rd edn. Academic Press, New York.
68. Reavill, C. & Stolerman, I.P. (1990) Locomotor activity in rats after administration of nicotinic agonists intracerebrally. Br. J. Pharmacol., 99, 273-278.
69. Redgrave, P., Prescott, T.J. & Gurney, K. (1999) The basal ganglia: a vertebrate solution to the selection problem? Neuroscience, 89, 1009-1023.
70. Schilstrom, B., Nomikos, G., Nisell, M., Hertel, P. & Svensson, T. (1998) N-Methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens. Neuroscience, 82, 781-789.
71. Schultz, W. (1998) Predictive reward signal of dopamine neurons. J. Neurophysiol., 80, 1-27.
72. Scroggs, R.S., Cardenas, C.G., Whittaker, J.A. & Kitai, S.T. (2001) Muscarine reduces calcium-dependent electrical activity in substantia nigra dopaminergic neurons. J. Neurophysiol., 86, 2966-2972.
73. Sorenson, E.M., Shiroyama, T. & Kitai, S.T. (1998) Postsynaptic nicotinic receptors on dopaminergic neurons in the substantia nigra pars compacta of the rat. Neuroscience, 87, 659-673.
74. Sziraki, I., Sershen, H., Hashim, A. & Lajtha, A. (2002) Receptors in the ventral tegmental area mediating nicotine-induced dopamine release in the nucleus accumbens. Neurochem. Res., 27, 253-261.
75. Tzschentke, T.M. (2001) Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog. Neurobiol., 63, 241-320.
76. Vilaro, M.T., Palacios, J.M. & Mengod, G. (1990) Localization of m5 muscarinic receptor mRNA in rat brain examined by in situ hybridization histochemistry. Neurosci. Lett., 114, 154-159.
77. Wang, H., Ng, K., Hayes, D., Gao, X., Forster, G., Blaha, C. & Yeomans, J. (2004) Decreased amphetamine-induced locomotion and improved latent inhibition in mice mutant for the M5 muscarinic receptor gene found in the human 15q schizophrenia region. Neuropsychopharmacology, 29, 2126-2139.
78. Weiner, D.M., Levey, A.I. & Brann, M.R. (1990) Expression of muscarinic acetylcholine and dopamine receptors mRNAs in rat basal ganglia. Proc. Natl. Acad. Sci. USA, 87, 7050-7054.
79. Wess, J. (1996) Molecular biology of muscarinic acetylcholine receptors. Crit. Rev. Neurobiol., 10, 69-99.
80. Wess, J. (2003) Novel insights into muscarinic acetylcholine receptor function using gene targeting technology. Trends Pharmacol. Sci., 24, 414-420.
81. Westerink, B.H., Kwint, H.F. & de Vries, J.B. (1996) The pharmacology of mesolimbic dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain. J. Neurosci., 16, 2605-2611.
82. Williams, J.H., Wellman, N.A., Geaney, O.P., Cowen, P.J., Feldon, J. & Rawlins, J.N.P. (1998) Reduced latent inhibition in people with schizophrenia: an effect of psychosis or of its treatment. Br. J. Psychiatry, 172, 243-249.
83. Winn, P., Brown, V.J. & Inglis, W.L. (1997) On the relationships between the striatum and the pedunculopontine tegmental nucleus. Crit. Rev. Neurobiol., 11, 241-261.
84. Wooltorton, J.R., Pidoplichko, V.I., Broide, R.S. & Dani, J.A. (2003) Differential sensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. J. Neurosci., 23, 3176-3185.
85. Yeomans, J. (1995) Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia. Neuropsychopharmacology, 12, 3-16.
86. Yeomans, J. & Baptista, M. (1997) Both nicotinic and muscarinic receptors in ventral tegmental area contribute to brain-stimulation reward. Pharmacol. Biochem. Behav., 57, 915-921.
87. Yeomans, J., Forster, G. & Blaha, C. (2001) M5 muscarinic receptors are needed for slow activation of dopamine neurons and for rewarding brain stimulation. Life Sci., 68, 2449-2456.
88. Yeomans, J.S., Kofrnan, O. & McFarlane, V. (1985) Cholinergic involvement in lateral hypothalamic rewarding brain stimulation. Brain Res., 329, 19-26.
89. Yeomans, J.S., Mathur, A. & Tampakeras, M. (1993) Rewarding brain stimulation: role of tegmental cholinergic neurons that activate dopamine neurons. Behav. Neurosci., 107, 1077-1087.
90. Yeomans, J.S., Takeuchi, J., Baptista, M., Flynn, D.D., Lepik, K., Nobrega, J., Fulton, J. & Ralph, M.R. (2000) Brain-stimulation reward thresholds raised by an antisense oligonucleotide for the M5 muscarinic receptor infused near dopamine cells. J. Neurosci., 20, 8861-8867.
91. Yin, R. & French, E. (2000) A comparison of the effects of nicotine on dopamine and non-dopamine neurons in the rat ventral tegmental area: An in vitro electrophysiological study. Brain Res. Bull., 51, 507-514.
92. Zheng, F. & Johnson, S.W. (2003) Metabotropic glutamate and muscarinic cholinergic receptor-mediated preferential inhibition of N-methyl-D-aspartate component of transmissions in rat ventral tegmental area. Neuroscience, 116, 1013-1020.
93. Zubieta, J.K. & Frey, K.A. (1993) Autoradiographic mapping of M3 muscarinic receptors in the rat brain. J. Pharmacol. Exp. Ther., 264, 415-422.